97265 ⎘
Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
ANTI-SLC3A2-APIS ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
#2RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS
#3MULTISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND PSMA AND 4-1BB AND METHODS OF USE THEREOF
#4COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION
#5CDH17 ANTIBODIES AND USES THEREOF
#6MODULATORS
#7FLT3 LIGAND BI-FUNCTIONAL MOLECULES FOR THROMBOPENIA AND ACUTE RADIATION SYNDROME
#8MULTISPECIFIC ANTIBODY WITH COMBINATION THERAPY FOR IMMUNO-ONCOLOGY
#9METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) IN COMBINATION WITH GLP-1 AGONISTS
#10IMPROVED DUAL SPECIFICITY POLYPEPTIDE MOLECULE
#11SERINE PROTEASE INHIBITOR KAZAL (SPIK) COMPOSITIONS AND METHODS
#12COMPOSITIONS AND METHODS COMPRISING ANTIBODIES THAT BIND TO COVALENT PEPTIDE CONJUGATES
#13COMPOUNDS USEFUL TO TREAT METABOLIC DISORDERS
#14Methods of Treating IL1RAP Associated Cancers with Anti Human Interleukin-1 Receptor Accessory Protein (IL1 RAP) Antibodies
#15PROTEOLYTICALLY CLEAVABLE CHIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF
#16ANTI-RAGE ANTIBODY, EXTRACELLULAR VESICLE, AND PREPARATION METHOD AND USE THEREOF
#17ENGINEERED SWITCHES FOR IMMUNE CELL ACTIVITY AND METHODS OF USE THEREOF
#18ANTIBODY EPITOPE
#19Treatment and Prophylaxis of Amyloidosis
#20HUMANIZED ANTI-BASIGIN ANTIBODIES AND THE USE THEREOF
#21METHODS AND MEANS FOR ATTRACTING IMMUNE EFFECTOR CELLS TO TUMOR CELLS
#22ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING MAGE-A
#23SITE-SPECIFIC CONJUGATION OF GLYCOSYLATED MONOCLONAL ANTIBODIES WITH TRANSGLUTAMINASE
#24SITE-SPECIFIC CONJUGATION OF GLYCOSYLATED MONOCLONAL ANTIBODIES WITH TRANSGLUTAMINASE
#25Anti-SIRPa Antibodies and Methods of Use Thereof
#26LTBP COMPLEX-SPECIFIC INHIBITORS OF TGFb AND USES THEREOF
#27T CELL RECEPTORS DIRECTED AGAINST JCHAIN AND USES THEREOF
#28Human Antigen Binding Proteins That Bind Beta-Klotho, FGF Receptors and Complexes Thereof
#29METHODS OF TREATING BLOOD DISORDERS WITH VWF-TARGETED MONOSPECIFIC ANTIBODIES
#30NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME
#31HUMAN CGRP RECEPTOR BINDING PROTEINS
#32METHODS OF TREATING NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS USING INTERLEUKIN-17 (IL-17) ANTAGONISTS
#33ANTI-HUMAN PAPILLOMAVIRUS (HPV) ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
#34ANTIBODIES THAT TARGET HLA-E-HOST PEPTIDE COMPLEXES AND USES THEREOF
#35Method for identifying deltaT-cell (or gammaT-cell) receptor chains or parts thereof that mediate an anti-tumour or an anti-infective response
#36PROTEIN S ANTIBODIES, METHODS OF MAKING AND USES THEREOF
#37ANTI-CD47 ANTIBODIES AND METHODS OF USE THEREOF
#38COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION
#39ANTI-HBV ANTIBODIES AND USES THEREOF
#40ANTI-CD25 ANTIBODY AGENTS
#41Anti-SIRPα antibodies and methods of use thereof
#42ANTIBODY MOLECULES TO CD138 AND USES THEREOF
#43ANTI-CD300F ANTIBODY AND USES THEREOF
#44ANTI-C1s ANTIBODY
#45TCR MIMIC MONOCLONAL ANTIBODIES REACTIVE WITH THE PHOSPHO-NEOANTIGEN PIRS2/HLA-A*02:01 COMPLEX AND USES THEREOF
#46ANTI-TREM-1 ANTIBODIES AND USES THEREOF
#47HLA-RESTRICTED EPITOPES ENCODED BY SOMATICALLY MUTATED GENES
#48MONOCLONAL ANTIBODY AGAINST D-DIMER AND DIAGNOSIS AGENT FOR DETECTING D-DIMER, CROSSLINKED FIBRIN AND ITS DERIVATIVES CONTAINING D-DIMER BY USING THE ANTIBODY
#49Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers
#50Antigen binding proteins specifically binding MAGE-A
#51HIGH CONCENTRATION PROTEIN FORMULATIONS WITH REDUCED VISCOSITY
#52T CELL RECEPTORS THAT BIND TO NY-ESO-1 AND METHODS OF USE THEREOF
#53USE OF ITOLIZUMAB TO REDUCE PHOSPHORYLATION OF CD6
#54PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS
#55Protein S antibodies, methods of making and uses thereof
#56CONJUGATE OR FUSION PROTEIN FOR CANCER THERAPY
#57COMPLEX-SPECIFIC ANTIBODIES AND ANTIBODY FRAGMENTS AND ITS USE
#58ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING MAGE-A
#59GENETIC VARIATIONS ASSOCIATED WITH BENIGN PAROXYSMAL POSITIONAL VERTIGO
#60CELL-FREE METHODS OF RECOMBINANT ANTIBODY PRODUCTION
#61Antigen binding receptors specific for mutated Fc domains
#62ANTIGEN-BINDING PROTEINS TARGETING SHARED ANTIGENS
#63COMPOSITIONS TARGETING NDC80/MHC COMPLEXES AND USES THEREOF
#64IMPROVED DUAL SPECIFICITY POLYPEPTIDE MOLECULE
#65TREATMENT OF TAUOPATHIES
#66MONOCLONAL ANTIBODIES DIRECTED TO PEPTIDE IN THE CONTEXT OF MHC AND METHODS OF MAKING AND USING MONOCLONAL ANTIBODIES
#67ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE
#68CHIMERIC POLYPEPTIDES AND USES THEREOF
#69Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
#70HUMAN LEUKOCYTE ANTIGEN RESTRICTED GAMMA DELTA T CELL RECEPTORS AND METHODS OF USE THEREOF
#71TUMOR SELECTIVE MACROPINOCYTOSIS-DEPENDENT RAPIDLY INTERNALIZING ANTIBODIES
#72A*03 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS
#73RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS
#74STROMAL GENE SIGNATURES FOR DIAGNOSIS AND USE IN IMMUNOTHERAPY
#75PROTEIN S ANTIBODIES, METHODS OF MAKING AND USES THEREOF
#76Anti-CD300F antibody and uses thereof
#77Anti-TIGIT Antibodies
#78METHODS AND MEANS FOR ATTRACTING IMMUNE EFFECTOR CELLS TO TUMOR CELLS
#79STABLE AQUEOUS ANTI-TFPI ANTIBODY FORMULATION
#80Antibodies to Plasminogen Activator Inhibitor-1 (PAI-1) and Uses Thereof
#81Cancer Neoepitopes
#82A*03 restricted peptides for use in immunotherapy against cancers and related methods
#83P116 antibodies
#84LTBP complex-specific inhibitors of TGFβ and uses thereof
#85A*03 restricted peptides for use in immunotherapy against cancers and related methods
#86PROTEOLYTICALLY CLEAVABLE CHIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF
#87Anti-SIRPa antibodies and methods of use thereof
#88Anti-LAG3 antibodies and antigen-binding fragments
#89ANTI-NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA 1 (NY-ESO-1) ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
#90BISPECIFIC NANOBODIES
#91ANTIBODY DIRECTED AGAINST THE APOE AMINO-TERMINAL FRAGMENT OF 12KDA
#92NOVEL MODULATORS
#93MULTISPECIFIC TREG BINDING MOLECULES
#94ANTIGEN-BINDING PROTEINS TARGETING SHARED ANTIGENS
#95Compositions and treatments for
#96DUAL SPECIFICITY POLYPEPTIDE MOLECULE
#97DUAL SPECIFICITY POLYPEPTIDE MOLECULE
#98METHODS OF USING MONOCLONAL ANTIBODIES TARGETING EPITOPES OF ASPH
#99DEVICE FOR DETECTION OF VITAMIN D METABOLITES
#100Anti Human Interleukin-1 Receptor Accessory Protein (IL1 RAP) Antibodies and Uses Thereof
#101Monoclonal antibodies against MHC-bound human dickkopf-1 peptides and uses thereof
#102LTBP complex-specific inhibitors of TGFβ and uses thereof
#103Antibody molecules that bind CD137 and OX40
#104COMBINATION THERAPIES FOR DELIVERY ACROSS THE BLOOD BRAIN BARRIER
#105Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use
#106ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF
#107Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)
#108ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF
#109ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF
#110ANTIBODY EPITOPE
#111ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF
#112ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF
#113Nucleic acids encoding anti-TREM-1 antibodies
#114Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
#115Anti-TREM-1 antibodies and uses thereof
#116COMPOUNDS AND COMPOSITIONS THAT INHIBIT OR PREVENT LIPOPROTEIN ENTRY INTO THE ENDOTHELIUM
#117T CELL RECRUITING POLYPEPTIDES BASED ON TCR ALPHA/BETA REACTIVITY
#118HUMAN FCRN-BINDING MODIFIED ANTIBODIES AND METHODS OF USE
#119Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same
#120Site-specific conjugation of glycosylated monoclonal antibodies with transglutaminase
#121NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME
#122HPV-SPECIFIC BINDING MOLECULES
#123MUSCARINIC ACETYLCHOLINE RECEPTOR BINDING AGENTS AND USES THEREOF
#124A*03 restricted peptides for use in immunotherapy against cancers and related methods
#125A*03 restricted peptides for use in immunotherapy against cancers and related methods
#126Antibody that recognizes neoepitope of activated interleukin-18 proteins and application thereof
#127Proteins and Uses
#128Compositions and methods for growth factor modulation
#129TGFβ antibodies, methods and uses
#130Serine protease inhibitor kazal (SPIK) compositions and methods
#131ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE
#132ABERRANT CELL-RESTRICTED IMMUNOGLOBULINS PROVIDED WITH A TOXIC MOIETY
#133Methods to create chemically-induced dimerizing protein systems for regulation of cellular events
#134Antibodies that bind interleukin-2 and uses thereof
#135Human CGRP receptor binding proteins
#136Human CGRP receptor binding proteins
#137Treatment of tauopathies
#138Method of cell therapy
#139COMPOUNDS USEFUL TO TREAT METABOLIC DISORDERS
#140ANTIGEN BINDING PROTEINS WHICH BIND TO THE pMHC HLA-DQ2.5:DQ2.5 PRESENTING A GLIADIN PEPTIDE
#141ANTIGEN-BINDING PROTEINS TARGETING SHARED ANTIGENS
#142MULTISPECIFIC ANTIBODY PRODUCT THAT BINDS TO DIFFERENT ROR1 EPITOPES
#143A*03 restricted peptides for use in immunotherapy against cancers and related methods
#144A*03 restricted peptides for use in immunotherapy against cancers and related methods
#145A*03 restricted peptides for use in immunotherapy against cancers and related methods
#146CL and/or CH1 mutated antibodies for drug conjugation
#147PEPTIDES FROM PIWIL1
#148Anti-CD25 antibody agents
#149Anti-CD25 for tumour specific cell depletion
#150LTBP complex-specific inhibitors of TGFβ and uses thereof
#151Anti-CD25 for tumour specific cell depletion
#152Antigen binding proteins specifically binding MAGE-A
#153ANTI-WT1/HLA-SPECIFIC ANTIBODIES
#154Methods of using monoclonal antibodies targeting epitopes of ASPH
#155Anti-CD25 for tumour specific cell depletion
#156Anti-CD25 for tumour specific cell depletion
#157Anti-CD25 for tumour specific cell depletion
#158Anti-CD25 antibody agents
#159Treatment and Prophylaxis of Amyloidosis
#160Anti-CD25 antibody agents
#161Chimeric polypeptides and uses thereof
#162T cell receptors and immune therapy using the same
#163Anti-IL-6/IL-6R antibodies and methods of use thereof
#164METHODS FOR PREDICTING CANCER DRUG RESPONSIVENESS
#165COMPLEX-SPECIFIC ANTIBODIES AND ANTIBODY FRAGMENTS AND ITS USE
#166Methods of producing an IL-1 RAP antibodies
#167Antibodies to LILRB2
#168Anti-CD83 antibodies and use thereof
#169BINDING MOLECULES TARGETING PATHOGENS
#170A*03 restricted peptides for use in immunotherapy against cancers and related methods
#171TfR selective binding compounds and related methods
#172A*03 restricted peptides for use in immunotherapy against cancers and related methods
#173High concentration protein formulations with reduced viscosity
#174Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy
#175CHIMERIC ANTIGEN RECEPTORS (CAR) TO SELECTIVELY TARGET PROTEIN COMPLEXES
#176Tumor selective macropinocytosis-dependent rapidly internalizing antibodies
#177Human antigen binding proteins that bind β-klotho, FGF receptors and complexes thereof
#178METHODS OF PURIFYING BISPECIFIC ANTIBODIES
#179Anti-GARP protein
#180Intranasal Delivery of Cell Permeant Therapeutics
#181CTLA4 binders
#182T cell receptors and immune therapy using the same
#183Engineered antibodies for the detection of phosphorylated tyrosine
#184COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION
#185COMPUTATIONAL AFFINITY MATURATION OF ANTIBODY LIBRARIES USING SEQUENCE ENUMERATION
#186T cell receptor-like antibody agents specific for EBV latent membrane protein 2A peptide presented by human HLA
#187Antibody variants transmigrating the blood-brain barrier and uses thereof
#188GARP-TGF-β 1 IGG antibodies
#189Antigen binding receptors specific for mutated Fc domains
#190Method of screening for anti-GARP antibodies
#191CONSTRUCTS TARGETING PSA PEPTIDE/MHC COMPLEXES AND USES THEREOF
#192PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS
#193COMPOSITIONS AND METHODS FOR ENHANCING THE KILLING OF TARGET CELLS BY NK CELLS
#194T CELL RECEPTOR LIKE ANTIBODIES
#195Anti-TIGIT antibodies
#196Methods for detecting 1,25-dihydroxyvitamin D and related antibodies
#197T cell receptors that bind to NY-ESO-1 and methods of use thereof
#198METHODS OF PREVENTING OR TREATING PAIN USING ANTI-NGF ANTIBODIES
#199Methods of treating cancer by administering inhibitory RNA molecules targeting protease serine 2 (PRSS2) expression
#200Heterodimeric proteins and preparation method thereof
#201THERAPIES BASED ON CONTROL OF REGULATORY T CELL STABILITY AND FUNCTION VIA A NEUROPILIN-1:SEMAPHORIN AXIS
#202*03 restricted peptides for use in immunotherapy against cancers and related methods
#203A*03 restricted peptides for use in immunotherapy against cancers and related methods
#204Monoclonal antibodies targeting epitopes of ASPH
#205Nucleic acids encoding GARP-TGF-beta 1 antibodies
#206Methods of screening compounds useful for treatment of a liver disease
#207CHIMERIC RECEPTORS, BIOSENSOR HOST CELLS AND METHODS/USES THEREOF
#208Anti-SIRPA antibodies and methods of use thereof
#209NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME FOR THE TREATMENT OF CANCER AND INFECTIOUS DISEASES
#210Artificial chemical entity comprising a DNA oligonucleotide aptamer that selectively binds MUC1 antigen
#211Antibody against trimeric TNFα complex
#212Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
#213Anti-CD25 antibody agents
#214Regeneratable Biosensor and Methods of Use Thereof
#215Immunoassay for collagen type VI
#216Anti-CD25 antibody agents
#217Anti-TREM-1 antibodies and uses thereof
#218Anti-alpha-synuclein antibodies and methods of use
#219Anti-CD25 antibody agents
#220T cell receptors and immune therapy using the same
#221T cell receptor-like antibodies specific for Foxp3-derived peptides
#222Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
#223T cell receptors and immune therapy using the same
#224USE OF ITOLIZUMAB TO REDUCE PHOSPHORYLATION OF CD6
#225ILT3 ligand
#226HPV-specific binding molecules
#227Treatment of tauopathies
#228Method for identifying δT-cell (or γT-cell) receptor chains or parts thereof that mediate an anti-tumour or an anti-infective response
#229Anti human interleukin-1 receptor accessory protein (IL1 RAP) antibodies and uses thereof
#230Proteolytically cleavable chimeric polypeptides and methods of use thereof
#231Long-acting PCSK9-specific binding protein and application thereof
#232Antibodies to LILRB2
#233Anti-TNF-alpha-antibodies and functional fragments thereof
#234Polypeptide exhibiting affinity to antibodies forming non-native three-dimensional structure
#235Broadly cross-reactive HIV-1-specific antibodies for prevention and treatment of HIV
#236GLYCOPROTEIN V INHIBITORS FOR USE AS COAGULANTS
#237Human leukocyte antigen restricted gamma delta T cell receptors and methods of use thereof
#238ABT-165 IN COMBINATION WITH FOLINIC ACID, 5-FLUOROURACIL, AND IRINOTECAN FOR THE TREATMENT OF CANCERS
#239Antibodies against Mac-1
#240Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof
#241COMPOUNDS USEFUL TO TREAT METABOLIC DISORDERS
#242Administration of a bispecific construct binding to CD33 and CD3 for use in a method for the treatment of myeloid leukemia
#243T cell recruiting polypeptides based on TCR alpha/beta reactivity
#244Antibody molecules to CD138 and uses thereof
#245IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#246Screening method of anticancer agent focused on function of HP1 and evaluation system
#247CHIMERIC POLYPEPTIDES AND USES THEREOF
#248Anti-LAG3 antibodies and antigen-binding fragments
#249Bispecific antibody targeting human p185 and vascular endothelial growth factor and application thereof
#250Device for detection of vitamin D metabolites
#251CROSS-LINKING POLYPEPTIDE THAT INDUCES APOPTOSIS
#252STROMAL GENE SIGNATURES FOR DIAGNOSIS AND USE IN IMMUNOTHERAPY
#253Compositions and methods for growth factor modulation
#254Anti-LAG3 antibodies and antigen-binding fragments
#255Anti-LAG3 antibodies and antigen-binding fragments
#256TIGIT-binding agents and uses thereof
#257TGFβ1-binding immunoglobulins and use thereof
#258METHODS OF PURIFYING ANTIBODIES
#259Antibody against a complex between human GARP and latent TGF-β
#260DUAL SPECIFICITY POLYPEPTIDE MOLECULE
#261DUAL SPECIFICITY POLYPEPTIDE MOLECULE
#262Dual specificity polypeptide molecule
#263Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody
#264T cell receptors and immune therapy using the same
#265Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
#266Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease
#267Modulators
#268TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
#269Anti-factor XI monoclonal antibodies and methods of use thereof
#270Anti-PD-L1 antibodies and uses thereof
#271Anti-PD-L1 antibodies and uses thereof
#272PEPTIDES FROM PIWIL1
#273High concentration protein formulations with reduced viscosity
#274MSLN targeting trispecific proteins and methods of use
#275GARP-TGF-beta 1 antibodies
#276T cell receptors and immune therapy using the same
#277Methods to create chemically-induced dimerizing protein systems for regulation of cellular events
#278Antibody-based molecules selective for the Ser404 epitope of Tau and their uses in the diagnosis and treatment of tauopathy
#279Monoclonal antibodies directed to peptide in the context of MHC and methods of making and using monoclonal antibodies
#280Compositions and treatments for
#281Neutralizing antibodies and methods of use thereof
#282COMBINATION THERAPIES OF HER2-TARGETED ANTIBODY-DRUG CONJUGATES
#283T cell receptor-like antibody agents specific for EBV latent membrane protein 2A peptide presented by human HLA
#284ANTIBODIES WHICH BIND TYPE I CANNABINOID RECEPTOR/ANGIOTENSIS II RECEPTOR HETEROMERS
#285Monoclonal antibodies against antithrombin beta
#286Anti-alpha-synuclein antibodies and methods of use
#287MUSCARINIC ACETYLCHOLINE RECEPTOR BINDING AGENTS AND USES THEREOF
#288COMPOSITIONS AND METHODS FOR USING ANTI-IL-34 ANTIBODIES TO TREAT NEUROLOGICAL DISEASES
#289Anti-PD-L1 antibodies and uses thereof
#290GDF11 BINDING PROTEINS AND USES THEREOF
#291Antibody Fusion Protein and Preparation Method and Use Thereof
#292Anti-CD83 antibodies and use thereof
#293Method for the in situ formation of bifunctional immunological complexes
#294Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same
#295Antibodies
#296ABERRANT CELL-RESTRICTED IMMUNOGLOBULINS PROVIDED WITH A TOXIC MOIETY
#297Regeneratable Biosensor and Methods of Use Thereof
#298T cell receptor-like antibodies specific for a PRAME peptide
#299HUMAN CGRP RECEPTOR BINDING PROTEINS
#300Cancer neoepitopes